Regulus Therapeutics Inc (RGLS) Stock
RGLS is no longer traded. Regulus Therapeutics was delisted from the Nasdaq in June 2025.
Prices on this page are historical; the last trade was June 23, 2025 at $8.14.
Regulus Therapeutics stock price history
RGLS final trading statistics
- Final close
- $8.14
- Final trading day
- Jun 23, 2025
- Market cap at delisting
- $563.57M
- Shares outstanding
- 69.23M
- Final 52-week range
- $0.83 – $8.35
- Avg. volume (final 3 mo.)
- 2,553,676
- All-time high (split-adj.)
- $2649.60 · Nov 2014
- All-time low (split-adj.)
- $0.79 · Mar 2023
- Return since IPO
- -98.4%
- Beta
- 0.37
- Book value / share
- $1.04
- Price / book
- 7.82
Regulus Therapeutics annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $0.00 | -$46.4M | -$0.87 |
| FY2023 | $0.00 | -$30.0M | -$1.59 |
| FY2022 | $0.00 | -$28.3M | -$1.90 |
| FY2021 | $10.0K | -$27.8M | -$3.30 |
| FY2020 | $10.01M | -$15.3M | -$5.50 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Regulus Therapeutics Inc
Regulus Therapeutics Inc. engages in the development of drugs designed to inhibit dysregulated microRNA targets for the benefit of patients with genetically based orphan diseases. The company develops farabursen, an anti-miR oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease. It is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was formerly known as Regulus Therapeutics LLC and changed its name to Regulus Therapeutics Inc. in January 2009. The company was incorporated in 2007 and is based in San Diego, California. As of June 25, 2025, Regulus Therapeutics Inc. operates as a subsidiary of Novartis AG.
Regulus Therapeutics stock FAQ
What happened to Regulus Therapeutics stock?
Regulus Therapeutics stock was delisted from the Nasdaq. Its final close was $8.14 on June 23, 2025.
Is RGLS stock still trading?
No. RGLS was delisted from the Nasdaq in June 2025 and no longer trades on a U.S. exchange.
What was the last price of RGLS stock?
RGLS closed at $8.14 on its final trading day, June 23, 2025, for a market value of about $563.57M.
What were Regulus Therapeutics's revenue and earnings in its last full fiscal year?
Regulus Therapeutics reported revenue of $0.00 and net income of -$46.4M in fiscal 2024, its last full year as a public company.
When did Regulus Therapeutics go public?
Regulus Therapeutics Inc stock began trading on October 4, 2012.